Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor

In this video, Candace Haddox, MD, discussed a few presentations from the Connective Tissue Oncology Society Annual Meeting that focused on how better understanding of sarcoma biology could lead to clinical advancement.

Healio spoke with Sandra D’Angelo, MD, about a study of rogaratinib in patients with succinate dehydrogenase-deficient gastrointestinal stromal tumor presented at the Connective Tissue Oncology Society Annual Meeting.